Looking for TB lung damage risk factors and blood markers
Part of Infections, Lungs & breathing clinical trials.
This study looks at what increases the risk of long-term lung damage after active pulmonary tuberculosis (TB). It also tests whether certain blood or other markers can predict who is more likely to have lung problems later.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 25 to 60.
- You have newly diagnosed active TB affecting the lungs.
- Your TB tests are not positive for smear or TB culture results.
- You do not have HIV infection.
- You do not have multidrug-resistant TB.
- You have visible lung tissue damage from TB (not just TB pleurisy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at your lung health and overall wellbeing after finishing treatment for tuberculosis (TB). It aims to understand how TB affects breathing and quality of life, so doctors can better support recovery.
This study looks at changes in the lungs and immune system before TB treatment and again after treatment. By sampling lung fluid and comparing it over time, researchers hope to learn signatures that reflect how TB responds to care.
This study looks at how tuberculosis affects the lungs and whether a pulmonary rehabilitation program (exercise, breathing exercises, education, and support) can help people with lung problems after TB. It aims to understand the disease better and improve breathing and quality of life.
This study looks at how the immune system and natural germs in the lungs work in people who have recently been in close contact with someone with active tuberculosis (TB). It aims to better understand how the body responds to TB exposure.
This study looks at how the immune system reacts in people with tuberculosis (TB), their close contacts, people with other lung diseases, and healthy volunteers. It aims to find better ways to diagnose and manage TB.
This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.
Hear when a new Pulmonary TB trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.